CompletedNot Applicable

Dynamic Neuromuscular Stabilization Training in Dysfunctional Voiding

Turkey (Türkiye)34 participantsStarted 2021-03-02

Plain-language summary

In this study, the effect of dynamic neuromuscular stabilization (DNS) exercise on urinary flow and quality of life in individuals with dysfunctional voiding was investigated. The 34 participants included in the study were randomized into two groups: the experiment in which DNS exercises were applied and the standard therapy group in which the manual application was applied. Uroflowmetry, Voiding Symptom Score (DVSS), Short Form-36 Quality of Life Assessment Short Form were applied to all participants at baseline and at week 6.

Who can participate

Age range

18 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Having been diagnosed with dysfunctional voiding, * Being between the ages of 18-75, * Not having a neurogenic bladder * Not having a urinary tract infection * Not having an obstacle to exercise, * Accepting and signing the Approval Form, * Not having undergone surgery in the last 6 months, Exclusion Criteria: * Not being cooperative * Not being able to participate in the treatment, * The use of drugs that will affect urination

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Uroflowmetry - Maximum flow rate (Qmax)

Timeframe: at the baseline and at week 6.

Uroflowmetry - Average flow rate (Qave)

Timeframe: at the baseline and at week 6.

Uroflowmetry - Corrected maximum flow rate (cQmax)

Timeframe: at the baseline and at week 6.

Uroflowmetry - Flow time (FT)

Timeframe: at the baseline and at week 6.

Uroflowmetry - Voiding volume (VV)

Timeframe: at the baseline and at week 6.

Uroflowmetry - Residual urine (RU)

Timeframe: at the baseline and at week 6.

Dysfunctional Voiding and Incontinence Symptom Score

Timeframe: at the baseline and at week 6.

Trial details

NCT IDNCT06040333

SponsorHalic University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-04-07

View on ClinicalTrials.gov More Dysfunctional Voiding trials

Plain-language summary

Who can participate

Age range

18 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Uroflowmetry - Maximum flow rate (Qmax)

Timeframe: at the baseline and at week 6.

Uroflowmetry - Average flow rate (Qave)

Timeframe: at the baseline and at week 6.

Uroflowmetry - Corrected maximum flow rate (cQmax)

Timeframe: at the baseline and at week 6.

Uroflowmetry - Flow time (FT)

Timeframe: at the baseline and at week 6.

Uroflowmetry - Voiding volume (VV)

Timeframe: at the baseline and at week 6.

Uroflowmetry - Residual urine (RU)

Timeframe: at the baseline and at week 6.

Dysfunctional Voiding and Incontinence Symptom Score

Timeframe: at the baseline and at week 6.